In this episode of StartUp Health NOW, we dive into one of the most fascinating innovation stories in health tech. Our guest is Chuck Papageorgiou, CEO of NeuroEM Therapeutics, a company that’s part of StartUp Health’s Alzheimer’s Moonshot Community and is making waves with a radically different approach to treating Alzheimer’s disease — using radio waves.

What started as a research study to prove that cell phones cause brain cancer led to an unexpected breakthrough: the very same radio frequencies used in phones appeared to improve brain health in mice with Alzheimer’s. The discovery sparked a scientific journey that has since included promising human trials, FDA Breakthrough Device designation, partnerships, and progress towards bringing this non-invasive, affordable, at-home therapy to millions.

Papageorgiou shares how NeuroEM’s wearable headset is helping untangle the brain’s toxic proteins, the science behind this counterintuitive tech, and why the impact could rival — or even surpass — that of current Alzheimer’s drugs.

If you’re looking for an inspiring story about accidental genius ideas, bold leadership, and breakthrough innovation in brain health, this one’s a must-listen.

Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of our Health Moonshot Community Membership. To schedule a call and see if you qualify to join and increase brand awareness through our multi-media storytelling efforts, submit our three-minute application. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit.

Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

AI has been quietly transforming healthcare for years, but the arrival of ChatGPT changed the game. Suddenly, everyone—from patients to investors—could see the real-world impact of AI in making healthcare more efficient and accessible.

One company leading this transformation is Mediktor, a pioneer in AI-powered symptom assessment. Before AI had its cultural moment, Mediktor—a member of the StartUp Health community since 2016—was already using it to help stratify patients and guide them to the right level of care. Now, they’re growing rapidly and shaping the future of AI in healthcare.

In this episode, we chat with Cristian Pascual, CEO & Co-founder of Mediktor, to discuss:

As AI continues to shape healthcare, companies must balance innovation with accuracy. Pascual shares insights on how to harness AI’s power while ensuring reliability and trust.

Tune in to explore the next wave of AI in healthcare—and what it means for patients, providers, and the industry at large.

Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of our Health Moonshot Community Membership. To schedule a call and see if you qualify to join and increase brand awareness through our multi-media storytelling efforts, submit our three-minute application. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit.

Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

We all know light therapy can brighten our mood, especially for those battling depression or seasonal affective disorder. But what if light could do so much more? In this week’s episode of StartUp Health NOW, we dive deep into the revolutionary work of StartUp Health community member Mai Nguyen, PhD, CEO & Co-founder of Optoceutics.

Forget what you think you know about light therapy. Nguyen and her team are pioneering a new frontier, demonstrating how precisely delivered light, through the eyes, can actually reprogram brain waves. This isn’t just about mood enhancement; it’s about potentially slowing the progression of neurodegenerative diseases like Alzheimer’s.

Join us for a fascinating conversation with Nguyen, a Berkeley researcher turned entrepreneur, as she discusses her groundbreaking device, currently marketed as a wellness tool, but with profound clinical aspirations. Discover how her collaboration with engineers in Copenhagen has led to a novel technology that’s already making waves.

This episode will challenge your perception of the lights around you and illuminate the future of brain health. Get ready to have your mind blown!

Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of our Health Moonshot Community Membership. To schedule a call and see if you qualify to join and increase brand awareness through our multi-media storytelling efforts, submit our three-minute application. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit.

Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

Imagine this: 73 million Americans are over 65. Among them, 10-20% experience mild cognitive impairment (MCI), a potential precursor to Alzheimer’s. Yet their primary care doctors, with only 14 minutes per patient, lack the time for crucial neurological screenings. This is a critical gap in our healthcare system, especially as groundbreaking Alzheimer’s research and therapies emerge, making early detection more vital than ever.

That’s where Cx Precision Medicine comes in.

In this episode, we sit down with Sid O’Bryant, PhD, and Danguole Altman, the team behind CxPM, a company in the StartUp Health Alzheimer’s Moonshot Community working to revolutionize early cognitive screening with a simple blood test. Their innovative diagnostic tool is designed to detect neurodegenerative diseases earlier, ensuring patients get the right care at the right time.

Discover how Cx Precision Medicine is empowering patients to get the right care at the right time, streamlining the diagnostic process and ultimately, improving lives. Join us as we explore the future of Alzheimer’s detection and the hope it brings.

Let’s get into it!

Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of our Health Moonshot Community Membership. To schedule a call and see if you qualify to join and increase brand awareness through our multi-media storytelling efforts, submit our three-minute application. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit.

Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

On this episode of StartUp Health NOW, we learn about the power of photobiomodulation, a light therapy that promotes healing at the cellular level. From treating seasonal affective disorder to wound healing, light therapy’s applications are expanding. We’re joined by Guillaume Blivet of REGEnLIFE, a member of the StartUp Health community who is pioneering research into using photobiomodulation to address Alzheimer’s disease. Learn how their unique approach, targeting both the brain and gut, shows promise in reducing inflammation and improving cellular health. We discuss the science, the promising early results, and the potential of this groundbreaking approach.

Tune in now as we learn how targeting the gut-brain connection with specific wavelengths of light could offer new hope for patients.

Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of our Health Moonshot Community Membership. To schedule a call and see if you qualify to join and increase brand awareness through our multi-media storytelling efforts, submit our three-minute application. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit.

Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

When your health is on the line, accurate diagnostics are crucial. But many blood tests suffer from false positives, false negatives, and frustrating gray areas. In this episode of StartUp Health NOW, host Logan Plaster sits down with John Forrest, CEO & Co-founder of Veravas, a member of the StartUp Health community, to discuss their groundbreaking solution.

Tune in for the conversation and learn how Veravas is turning the tide on diagnostic uncertainty.

Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of our Health Moonshot Community Membership. To schedule a call and see if you qualify to join and increase brand awareness through our multi-media storytelling efforts, submit our three-minute application. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit.

Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

Are health tech founders building what the market actually needs? At StartUp Health, we see firsthand their biggest challenge: achieving product-market fit. But it’s more than just market alignment. Investor Robert Garber of 7wireVentures calls it “contract-market fit”—proof that people will pay.

This week, we talk with Robin Roberts, CEO & Founder of DatosX, a company in the StartUp Health community that is helping digital health startups achieve just that.

Listen in as Roberts shares his insights on achieving product-market fit and contract-market fit in the digital health space.

The Access to Care Moonshot Community is comprised of mission-aligned founders and CEOs collaborating to accelerate breakthroughs to deliver quality care to everyone, regardless of location or income.

Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of our Health Moonshot Community Showcase Membership. To schedule a call and see if you qualify to join and increase brand awareness through our multi-media storytelling efforts, submit our three-minute application. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit.

Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

Ever wonder where the next big breakthrough in health will come from? Sometimes, the most innovative solutions arise from the most unexpected places. This week’s podcast episode dives into the fascinating world of a neurosurgeon who’s revolutionizing glucose monitoring. Join us as we explore the groundbreaking work of Dr. Casey Halpern, co-founder of SynchNeuro, who is changing cardiometabolic care via the brain.

We discuss:

Tune in to discover how SynchNeuro – a member of our Cardiometabolic Health Moonshot Community – is poised to reshape the landscape of cardiometabolic health and empower individuals to take control of their wellbeing.

For years, chronic health problems like heart disease and Type 2 diabetes have grown, becoming some of society’s biggest killers. Thankfully, there’s a generation of entrepreneurs tackling the issue from every angle. In the Cardiometabolic Health Moonshot Community, mission-aligned founders and CEOs collaborate to accelerate breakthroughs in cardiometabolic disease prevention, diagnosis, monitoring, management, and cures.

Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of our Health Moonshot Community Showcase Membership. To schedule a call and see if you qualify to join and increase brand awareness through our multi-media storytelling efforts, submit our three-minute application. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit.

Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

This idea called “food as medicine” isn’t new. People have been talking for decades about how the foods we put in our body play a bigger role in preventative health and disease management than any drug or medication we could.

But it’s always been on the fringe. Partly because it’s difficult to do the studies that clinically prove that foods can be as effective as medications. And second, which is related, there hasn’t been much funding for this kind of work.

So, what’s changed? To answer that question, we sat down with Victor Penev, CEO & Founder of Edamam, a longtime member of the StartUp Health Community. Victor’s created what may be the world’s largest repository of food data. But he’s also a futurist with a keen eye on where the industry is heading.

In our conversation Penev explains how the uptake in GLP-1s and generative AI have come together in a fascinating way that opens up new opportunities in nutrition. Importantly, it may open up new funding sources and innovative business models.

On that note: StartUp Health has formally kicked off our Food as Medicine Health Moonshot Community, so if you or someone you know is a founder working in nutrition, someone with a passion to use food to make the world a healthier place, we’re accepting applications at StartUpHealth.com.

Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of our Health Moonshot Community Showcase Membership. To schedule a call and see if you qualify to join and increase brand awareness through our multi-media storytelling efforts, submit our three-minute application. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. Learn more and apply today.

Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

What if a single scan could not only diagnose existing health issues but also predict future problems and help prevent them? That’s the groundbreaking vision behind Imaginostics, a startup co-founded by Codi Gharagouzloo, PhD. A new member of the StartUp Health community, Imaginostics creates innovative, non-invasive diagnostic solutions using breakthrough quantitative imaging biomarkers to provide new insight in health and disease.

In this episode, StartUp Health co-founder Unity Stoakes interviews Gharagouzloo during JPM Week in San Francisco to explore the science behind Imaginostics and the unique technology they’re developing to revolutionize preventative health. You’ll also hear Gharagouzloo’s fascinating founder journey, from a troublemaking youth to a physicist with a soul-deep passion for transforming healthcare.

With $5M raised and an FDA breakthrough designation in hand, Imaginostics is making waves. Don’t miss this inspiring story of innovation, passion, and the pursuit of better health for all.Tune in now!

Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of our Health Moonshot Community Showcase Membership. To schedule a call and see if you qualify to join and increase brand awareness through our multi-media storytelling efforts, submit our three-minute application. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. Learn more and apply today.

Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.